Zyprexa and Erbitux drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zyprexa (olanzapine) and Erbitux (cetuximab). Common drug interactions include endocarditis among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Zyprexa and Erbitux. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Zyprexa?

Zyprexa has active ingredients of olanzapine. It is often used in bipolar disorder. eHealthMe is studying from 64,724 Zyprexa users. Check the latest studies of Zyprexa.

What is Erbitux?

Erbitux has active ingredients of cetuximab. It is often used in cancer. eHealthMe is studying from 19,276 Erbitux users. Check the latest studies of Erbitux.

On Jul, 26, 2026

13 people who take Zyprexa and Erbitux together, and have interactions are studied.

What are the common drug interactions of Zyprexa and Erbitux, by gender? *:

female:

Endocarditis (inflammation in heart muscle)
Platelet count decreased
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Pyrexia (fever)
Staphylococcal infection (an infection with staphylococcus bacteria)
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
Nausea (feeling of having an urge to vomit)
Anaemia (lack of blood)
Asthenia (weakness)
Confusional state

male:

Asthenia (weakness)
Confusional state
Somnolence (a state of near-sleep, a strong desire for sleep)
Vomiting
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Fatigue (feeling of tiredness)
Gastrointestinal necrosis (destruction of gastrointestinal organ)
Hyperthermia (body temperature greatly above normal)
Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)
Overdose

What are the common drug interactions of Zyprexa and Erbitux, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Dyspnoea (difficult or laboured respiration)

40-49:

Asthenia (weakness)
Confusional state
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Fatigue (feeling of tiredness)
Hyperthermia (body temperature greatly above normal)
Overdose
Rash
Renal failure (kidney dysfunction)
Respiratory rate decreased (less breathing rate/min)
Somnolence (a state of near-sleep, a strong desire for sleep)

50-59:

Asthenia (weakness)
Optic neuritis (optic nerve inflammation)

60+:

Endocarditis (inflammation in heart muscle)
Platelet count decreased
Diarrhoea
Disease progression
Gastrointestinal necrosis (destruction of gastrointestinal organ)
Haematuria (presence of blood in urine)
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)

What are the existing conditions these people have? *

Colon Cancer: 4 people, 30.77%
Rectal Cancer (cancer of rectum): 3 people, 23.08%
Cancer Pain: 3 people, 23.08%
Hypopharyngeal Cancer: 2 people, 15.38%
Tumor: 1 person, 7.69%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 7.69%
Nausea (feeling of having an urge to vomit): 1 person, 7.69%
Insomnia (sleeplessness): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Zyprexa and Erbitux?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously